Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

House Votes

This proposal makes Medicaid support education for people with sickle cell disease about a rare, aggressive kidney cancer called renal medullary carcinoma. It directs Medicaid to offer incentives so states and providers teach patients about the risk and what to watch for. The goal is to help people get information early, so they can seek care sooner if symptoms appear.

Key points:

• Who is affected: People with sickle cell disease who get care through Medicaid.
• What changes: Medicaid would provide incentives to deliver education on the risk of renal medullary carcinoma to these patients.
• When: Starts on the date the law is enacted.